Use of an integrated pan-cancer oncology enrichment NGS assay to measure tumour mutational burden and detect clinically actionable variants

Valerie Pestinger; Matthew Smith; Toju Sillo; John M Findlay; Jean-Francois Laes; Gerald Martin; Gary Middleton; Phillipe Taniere; Andrew D Beggs

doi:10.1101/2020.02.01.20019992

Use of an integrated pan-cancer oncology enrichment NGS assay to measure tumour mutational burden and detect clinically actionable variants

Valerie Pestinger
, Matthew Smith
, Toju Sillo
, John M Findlay
, Jean-Francois Laes
, Gerald Martin
, Gary Middleton
, Phillipe Taniere
, Andrew D Beggs

Research output: Working paper/Preprint › Preprint

Original language	English
Publisher	medRxiv
DOIs	https://doi.org/10.1101/2020.02.01.20019992
Publication status	Published - 4 Feb 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1101/2020.02.01.20019992

Cite this

@techreport{c73fd5341d5247c39bf820d7e5b3a07b,

title = "Use of an integrated pan-cancer oncology enrichment NGS assay to measure tumour mutational burden and detect clinically actionable variants",

author = "Valerie Pestinger and Matthew Smith and Toju Sillo and Findlay, \{John M\} and Jean-Francois Laes and Gerald Martin and Gary Middleton and Phillipe Taniere and Beggs, \{Andrew D\}",

year = "2020",

month = feb,

day = "4",

doi = "10.1101/2020.02.01.20019992",

language = "English",

publisher = "medRxiv",

type = "WorkingPaper",

institution = "medRxiv",

}

TY - UNPB

T1 - Use of an integrated pan-cancer oncology enrichment NGS assay to measure tumour mutational burden and detect clinically actionable variants

AU - Pestinger, Valerie

AU - Smith, Matthew

AU - Sillo, Toju

AU - Findlay, John M

AU - Laes, Jean-Francois

AU - Martin, Gerald

AU - Middleton, Gary

AU - Taniere, Phillipe

AU - Beggs, Andrew D

PY - 2020/2/4

Y1 - 2020/2/4

UR - https://doi.org/10.1101/2020.02.01.20019992

U2 - 10.1101/2020.02.01.20019992

DO - 10.1101/2020.02.01.20019992

M3 - Preprint

BT - Use of an integrated pan-cancer oncology enrichment NGS assay to measure tumour mutational burden and detect clinically actionable variants

PB - medRxiv

ER -